Form 4 for GYRE GYRE THERAPEUTICS, INC.
Accepted 2026-05-20 16:01:24 ET · period of report 2026-05-18 · accession 0001140361-26-022235 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-20 16:01 | 2026-05-18+ | GYRE | Ye Weiguo | COO | M - OptEx | $0.75 | +9,320 | 709.1K | +1% | +$6,990 |
| DM | 2026-05-20 16:01 | 2026-05-18+ | GYRE | Ye Weiguo | COO | S - Sale+OE | $6.38 | -9,320 | 700.0K | -1% | -$59.4K |
| DM | 2026-05-20 16:01 | 2026-05-18+ | GYRE | Ye Weiguo | COO | M - OptEx | $0.00 | -9,320 | 927.1K | -1.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-18 | M | A | 200 | $0.75 | 700,200 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-18 | S | D | 200 | $6.62 | 700,000 | D | — | — | (F1) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.6102 to $6.6215. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2026-05-19 | M | A | 9,120 | $0.75 | 709,120 | D | — | — | |
| 4 | Common | Common Stock | 2026-05-19 | S | D | 9,120 | $6.37 | 700,000 | D | — | — | (F2) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.3002 to $6.4119. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-05-18 | M | D | 200 | $0.00 | 936,235 | D | $0.75 · — to 2030-10-31 | 200 Common Stock | (F3) These options are vested in full. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-05-19 | M | D | 9,120 | $0.00 | 927,115 | D | $0.75 · — to 2030-10-31 | 9,120 Common Stock | (F3) These options are vested in full. |